NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

ConferenceNeutral

AI Analysis

Summary

NurExone Biologic Inc. announced participation in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference on September 9-10, 2026, in New York City to present on its exosome-based regenerative therapy platform.

Importance:2/10

Sentiment:

0.00

conferenceexosome-based therapiesregenerative medicineinvestor presentation

Related Companies

$NRX

Read the original article

Published by GlobeNewswire Pharma on August 28, 2026 8:01 PM

Read Original